Mirum Pharmaceuticals, Inc. — All Filings
602 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001547959-26-000002 | Jan 16, 2026 | Jan 15, 2026 |
| 144 | — | 0001950047-26-000431 | Jan 15, 2026 | — |
| 8-K | 8-K | 0001759425-26-000004 | Jan 12, 2026 | — |
| 4 | — | 0001614740-26-000001 | Jan 2, 2026 | Dec 31, 2025 |
| 4 | — | 0001240122-25-000011 | Dec 23, 2025 | Dec 19, 2025 |
| 4 | — | 0001547959-25-000008 | Dec 23, 2025 | Dec 22, 2025 |
| 144 | — | 0001950047-25-010594 | Dec 22, 2025 | — |
| 144 | — | 0001950047-25-010541 | Dec 19, 2025 | — |
| 8-K | 8-K | 0001193125-25-326822 | Dec 19, 2025 | — |
| 4 | — | 0001547959-25-000007 | Dec 19, 2025 | Dec 18, 2025 |
| 8-K | 8-K | 0001193125-25-325825 | Dec 19, 2025 | Dec 18, 2025 |
| 144 | — | 0001950047-25-010493 | Dec 18, 2025 | — |
| 8-K | 8-K | 0001193125-25-310611 | Dec 8, 2025 | Dec 6, 2025 |
| 4 | — | 0001240122-25-000007 | Dec 2, 2025 | Dec 1, 2025 |
| 144 | — | 0001950047-25-009503 | Dec 1, 2025 | — |
| 4 | — | 0001240122-25-000006 | Nov 25, 2025 | Nov 21, 2025 |
| 144 | — | 0001950047-25-009188 | Nov 21, 2025 | — |
| 4 | — | 0001614740-25-000005 | Nov 20, 2025 | Nov 18, 2025 |
| 8-K | 8-K | 0001759425-25-000057 | Nov 17, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-003107 | Nov 14, 2025 | — |
| SCHEDULE 13D/A | — | 0001231919-25-000420 | Nov 4, 2025 | — |
| 10-Q | 10-Q | 0001759425-25-000054 | Nov 4, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001759425-25-000053 | Nov 4, 2025 | — |
| 4 | — | 0001415889-25-024462 | Sep 12, 2025 | Sep 11, 2025 |
| 4 | — | 0001415889-25-024463 | Sep 12, 2025 | Sep 11, 2025 |
| 144 | — | 0001950047-25-006973 | Sep 11, 2025 | — |
| 4 | — | 0001415889-25-024128 | Sep 10, 2025 | Sep 8, 2025 |
| S-8 | S-8 | 0001759425-25-000045 | Sep 9, 2025 | — |
| 144 | — | 0001950047-25-006827 | Sep 8, 2025 | — |
| SCHEDULE 13D/A | — | 0001415889-25-022494 | Aug 20, 2025 | — |
| 4 | — | 0001415889-25-021521 | Aug 12, 2025 | Aug 11, 2025 |
| 4 | — | 0001415889-25-021522 | Aug 12, 2025 | Aug 11, 2025 |
| S-3ASR | S-3ASR | 0001193125-25-178937 | Aug 12, 2025 | — |
| 144 | — | 0001950047-25-005599 | Aug 11, 2025 | — |
| 4 | — | 0001415889-25-021350 | Aug 8, 2025 | Aug 7, 2025 |
| 4 | — | 0001415889-25-021351 | Aug 8, 2025 | Aug 7, 2025 |
| 144 | — | 0001950047-25-005530 | Aug 7, 2025 | — |
| 144 | — | 0001950047-25-005528 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0001759425-25-000041 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001759425-25-000040 | Aug 6, 2025 | — |
| 144 | — | 0001950047-25-004832 | Jul 3, 2025 | — |
| 4 | — | 0001415889-25-019378 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | — | 0001415889-25-017188 | Jun 13, 2025 | Jun 11, 2025 |
| 144 | — | 0001950047-25-004131 | Jun 11, 2025 | — |
| 4 | — | 0001415889-25-015570 | Jun 4, 2025 | Jun 2, 2025 |
| 144 | — | 0001950047-25-003778 | Jun 3, 2025 | — |
| 4 | — | 0001415889-25-015303 | Jun 2, 2025 | May 29, 2025 |
| 4 | — | 0001415889-25-015304 | Jun 2, 2025 | May 29, 2025 |
| 4 | — | 0001415889-25-015305 | Jun 2, 2025 | May 29, 2025 |
| 4 | — | 0001415889-25-015306 | Jun 2, 2025 | May 29, 2025 |